118 related articles for article (PubMed ID: 38352986)
21. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, biological evaluation, and in silico studies of 2-aminobenzothiazole derivatives as potent PI3Kα inhibitors.
Haider K; Ahmad K; Najmi AK; Das S; Joseph A; Shahar Yar M
Arch Pharm (Weinheim); 2022 Oct; 355(10):e2200146. PubMed ID: 35665957
[TBL] [Abstract][Full Text] [Related]
23. Design and Synthesis of Novel Celecoxib Analogues with Potential Cytotoxic and Pro-apoptotic Activity against Breast Cancer Cell Line MCF-7.
Abdelhaleem EF; Kassab AE; El-Nassan HB; Khalil OM
Med Chem; 2022; 18(8):903-914. PubMed ID: 35264093
[TBL] [Abstract][Full Text] [Related]
24. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of 3,5-dihydroxy-7,8-dimethoxy-2-(4-methoxyphenyl)benzopyran-4-one derivatives as anticancer agents.
Singh S; Ahmad A; Raghuvanshi DS; Hasanain M; Agarwal K; Dubey V; Fatima K; Alam S; Sarkar J; Luqman S; Khan F; Tandon S; Gupta A
Bioorg Med Chem Lett; 2016 Nov; 26(21):5322-5327. PubMed ID: 27671497
[TBL] [Abstract][Full Text] [Related]
26. New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Abbas SH; Abd El-Hafeez AA; Shoman ME; Montano MM; Hassan HA
Bioorg Chem; 2019 Feb; 82():360-377. PubMed ID: 30428415
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological explorations of eco-friendly amide substituted (Z)-β-enaminones as anti-breast cancer drugs.
Subramamiam P; Ramasubbu C; Athiramu S; Arumugam S; Alagumuthu M
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800244. PubMed ID: 30515835
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, docking and in vitro anticancer evaluation of some new benzopyrone derivatives.
El-Ansary SL; Hussein MM; Abdel Rahman DE; Abdel Ghany LM
Bioorg Chem; 2014 Apr; 53():50-66. PubMed ID: 24607350
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and In Vitro Cytotoxicity of Novel Halogenated Dihydropyrano[3,2-b]Chromene Derivatives.
Sabouri S; Faghih-Mirzaei E; Abaszadeh M
Acta Chim Slov; 2022 Dec; 69(4):920-927. PubMed ID: 36562167
[TBL] [Abstract][Full Text] [Related]
30. Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells.
Kishk SM; Eltamany EE; Nafie MS; Khinkar RM; Hareeri RH; Elhady SS; Yassen ASA
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235247
[TBL] [Abstract][Full Text] [Related]
31. New Ferrocene Formates Bearing Isoxazole Moieties: Synthesis, Characterization, X-ray Crystallography, and Preliminarily Cytotoxicity against A549, HCT116, and MCF-7 Cell Lines.
Yong J; Lu C; Yang M; Wu X
Curr Pharm Des; 2022; 28(34):2835-2841. PubMed ID: 35996233
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and molecular modeling of coumarin derivatives as MDM2 inhibitors targeting breast cancer.
Ahmed EY; Abdel Latif NA; Nasr T; Awad HM; Abdelhafez OM
Chem Biol Drug Des; 2022 Apr; 99(4):609-619. PubMed ID: 35156778
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel chromeno-annulated cis-fused pyrano[3,4-c]benzopyran and naphtho pyran derivatives via domino aldol-type/hetero Diels-Alder reaction and their cytotoxicity evaluation.
Madda J; Venkatesham A; Naveen Kumar B; Nagaiah K; Sujitha P; Ganesh Kumar C; Rao TP; Jagadeesh Babu N
Bioorg Med Chem Lett; 2014 Sep; 24(18):4428-4434. PubMed ID: 25172420
[TBL] [Abstract][Full Text] [Related]
35. Discovery and synthesis of 2-amino-1-methyl-1H-imidazol-4(5H)-ones as GPCR ligands; an approach to develop breast cancer drugs via GPCR associated PAR1 and PI3Kinase inhibition mechanism.
Ashok SR; Shivananda MK; Manikandan A; Chandrasekaran R
Bioorg Chem; 2019 May; 86():641-651. PubMed ID: 30822721
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, molecular properties and comparative docking and QSAR of new 2-(7-hydroxy-2-oxo-2H-chromen-4-yl)acetic acid derivatives as possible anticancer agents.
Elhenawy AA; Al-Harbi LM; El-Gazzar MA; Khowdiary MM; Moustfa A
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Jul; 218():248-262. PubMed ID: 31003050
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, molecular docking, and in-vitro studies of pyrimidine-2-thione derivatives as antineoplastic agents via potential RAS/PI3K/Akt/JNK inhibition in breast carcinoma cells.
Salem MM; Gerges MN; Noser AA
Sci Rep; 2022 Dec; 12(1):22146. PubMed ID: 36550279
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
[TBL] [Abstract][Full Text] [Related]
39. New 2-alkoxycyanopyridine derivatives as inhibitors of EGFR, HER2, and DHFR: Synthesis, anticancer evaluation, and molecular modeling studies.
Hawas SS; El-Sayed SM; Elzahhar PA; Moustafa MA
Bioorg Chem; 2023 Dec; 141():106874. PubMed ID: 37769524
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of Novel Fatty Substituted 4-methyl-2HChromen-2-one via Cross Metathesis: Potential Antioxidants and Chemotherapeutic Agents.
Yelchuri V; Prasad RB; Karuna MS; Poornachandra Y; Kumar CG
J Oleo Sci; 2016 Dec; 65(12):1023-1031. PubMed ID: 27829607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
